APPLICATION
ANDA078112
TYPE
ANDA
ORIGINAL APPROVAL
2007-03-08
LATEST ACTION
2012-01-31
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued
Products
DIDANOSINEDiscontinued
DIDANOSINE 10MG/ML · FOR SOLUTION · ORAL
Approval history
2012-01-31Labeling · Supplement 4AP
2011-12-27Labeling · Supplement 3AP
2010-03-29Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.